Tumor induced osteomalacia

1Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Tumor induced osteomalacia (TIO) is a rare paraneoplastic syndrome typically caused by small endocrine tumors that secrete fibroblast growth factor 23(FGF23). TIO is clinically characterized by progressive muskuloskeletal pain, fatigue, proximal muscle weakness, and multiple fractures that lead to long-term disability. Due to the non-specific symptoms of the disease, it may take several years for them to be properly diagnosed and treated, so it is important to better inform about this rare paraneoplastic syndrome.

Cite

CITATION STYLE

APA

Filipová, L., & Lazúrová, I. (2021). Tumor induced osteomalacia. Vnitrni Lekarstvi, 67(8), E19–E22. https://doi.org/10.36290/vnl.2021.130

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free